Aspirin inhibits vascular plasminogen activator activity in vivo: studies utilizing a new assay to quantity plasminogen activator activityLEVIN, R. I; HARPEL, P. C; WEIL, D et al.The Journal of clinical investigation. 1984, Vol 74, Num 2, pp 571-580, issn 0021-9738Article

Spectrophotometric determination of tranexamic acid with chloranilWAHBI, A.-A. M; LOTFI, E. A; ABOUL-ENEIN, H. Y et al.Talanta (Oxford). 1984, Vol 31, Num 1, pp 77-78, issn 0039-9140Article

Synthesis of 3 -substituted -5 -(4-carboxycyclohexylmethyl)-tetrahydro-2H -1,3,5 -thiadiazine -2 -thione derivatives as antifibrinolytic and antimicrobial agentsOZCELIK, Azime Berna; ERSAN, Seyhan; URAL, Ali Ugur et al.Arzneimittel-Forschung. 2007, Vol 57, Num 8, pp 554-559, issn 0004-4172, 6 p.Article

Perioperative use of modified thrombelastography in factor XI deficiency : a helpful method to assess drug effectsDIRKMANN, D; HANKE, A. A; GÖRLINGER, K et al.Acta anaesthesiologica scandinavica. 2007, Vol 51, Num 5, pp 640-643, issn 0001-5172, 4 p.Article

Determinants of Bleeding Risk in Patients on Antithrombotic and Antifibrinolytic DrugsMEIJER, Karina; SCHULMAN, Sam.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 8, pp 762-771, issn 0094-6176, 10 p.Article

Le traitement des épistaxis du quotidien à l'exceptionel = Treatment of epistoxis: everyday and unusual aspectsBASSET, J.-M.Gazette médicale de France (1969). 1984, Vol 91, Num 16, pp 104-106, issn 0016-5557Article

Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemiaVELASCO, F; TORRES, A; ANDRES, P et al.Thrombosis and haemostasis. 1984, Vol 52, Num 1, pp 81-84, issn 0340-6245Article

Antifibrinolytics in subarachnoid hemorrhageHACHINSKI, V.Archives of neurology (Chicago). 1987, Vol 44, Num 1, issn 0003-9942, 118Article

Topical application of antifibrinolytic drugs for on-pump cardiac surgery : a systematic review and meta-analysisABRISHAMI, Amir; CHUNG, Frances; WONG, Jean et al.Canadian journal of anaesthesia. 2009, Vol 56, Num 3, pp 202-212, issn 0832-610X, 11 p.Article

Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?ZUFFEREY, Paul; MERQUIOL, Fanette; LAPORTE, Silvy et al.Anesthesiology (Philadelphia). 2006, Vol 105, Num 5, pp 1034-1046, issn 0003-3022, 13 p.Article

Hemostatic therapy revisitedHORROW, J. C.Anesthesiology clinics of North America. 1994, Vol 12, Num 1, pp 91-117, issn 0889-8537Article

Effects of tranexamic acid on the conversion of glu-plasminogen I and II to its lys-formsTAKADA, A; TAKADA, Y.Thrombosis research. 1985, Vol 40, Num 2, pp 171-179, issn 0049-3848Article

Antifibrinolytic therapy: new data and new conceptsLEVY, Jerrold H.Lancet (British edition). 2010, Vol 376, Num 9734, pp 3-4, issn 0140-6736, 2 p.Article

Effects of EACA on thrombin generation as measured by the chromagen S2238SLOAN, I. G; FIRKIN, B. G.Thrombosis research. 1986, Vol 44, Num 6, pp 761-769, issn 0049-3848Article

Mafenide (sulfamylon^TM) inhibits plasmin fibrinolytic activityWEISDORF, D. J; ALDRIDGE, J. H.Thrombosis and haemostasis. 1988, Vol 59, Num 3, pp 440-444, issn 0340-6245Article

Tranexamic acid in remote damage control resuscitationRAPPOLD, Joseph F; PUSATERI, Anthony E.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 1, issn 0041-1132, S96-S99, SUPConference Paper

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patientsGAREWAL, H. S; DURIE, B. G. M.Scandinavian journal of haematology. 1985, Vol 35, Num 5, pp 497-500, issn 0036-553XArticle

A direct antifibrinolytic agent in major orthopedic surgerySAMAMA, Charles Marc.Orthopedics (Thorofare). 2004, Vol 27, Num 6, pp s675-s680, issn 0147-7447, SUPArticle

Troubles hémorragiques en périménopause. Place du traitement médicalQUEREUX, Christian; GRAESSLIN, Olivier.Reproduction humaine et hormones. 2003, Vol 16, Num 5, pp 297-301, issn 0994-3919, 5 p.Conference Paper

Effects of tranexamic acid on fibrinolysis, fibrinogenolysis and amidolysisTAKADA, A; MAKINO, Y; TAKADA, Y et al.Thrombosis research. 1986, Vol 42, Num 1, pp 39-47, issn 0049-3848Article

ANTIFIBRINOLYTIC ACTIVITY OF HUMAN SALIVA COMPONENTSHAZE H; ELDOR A; GARFUNKEL AA et al.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 1-2; PP. 231-236; BIBL. 17 REF.Article

PROPRIETES ANTIFIBRINOLYTIQUE ET ANTIMYCOSIQUE DE LA TETRAHYDRO-THIADIAZINE-1,3,5 THIONE-2KLEKING GR; VYURBAKH G.1976; FARMAKOL. I TOKSIKOL.; S.S.S.R.; DA. 1976; VOL. 39; NO 4; PP. 432-436; ABS. ANGL.; BIBL. 1/2 P.Article

Tranexamic Acid for Trauma Patients: A Critical Review of the LiteratureCAP, Andrew P; BAER, David G; ORMAN, Jean A et al.The Journal of trauma, injury, infection, and critical care. 2011, Vol 71, Num 1, issn 1079-6061, S9-S14, SUPConference Paper

MENORRHAGIA AND TREATMENT WITH AMINOCAPROIC ACID AS ASSESSED IN A REVIEW BY A GROUP OF RANDOMLY SELECTED GENERAL PRACTITIONERS.LAUDER MM; LAUDER AD.1977; BRIT. J. CLIN. PRACT.; G.B.; DA. 1977; VOL. 31; NO 1-3; PP. 14-16 (2P.); BIBL. 5 REF.Article

NATURAL AND SYNTHETIC INHIBITORS OF FIBRINOLYSIS.1977; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1977; NO 415; PP. 526-543; BIBL. DISSEM.; (TOP. HEMATOL. INT. CONGR. HEMATOL. 16. PROC.; KYOTO; 1976)Conference Paper